Keyword: Novartis

Plant Construction & Process Technology

Live-Broadcasting of Bioprocesses

10.09.2019 - The quality specifications of biopharmaceuticals are enormous and require a long list of time-consuming analytics. A big disadvantage of these analytics so far was, that their...

Strategy & Management

Continuous Processing

10.09.2019 - Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...

News

Lonza to Acquire Swiss Facility from Novartis

02.07.2019 - Swiss fine chemicals producer and drug developer Lonza has signed a binding agreement to acquire a sterile drug product fill & finish plant from Novartis, the first such facility...

News

Novartis may Settle US Lawsuit for $1 billion

21.05.2019 - Novartis may be close to a billion-dollar settlement with the US government to resolve a whistleblower lawsuit accusing the Swiss pharmaceuticals giant of bribing doctors to boost...

News

Codexis Signs License Deal with Novartis

17.05.2019 - US protein engineering company Codexis has signed a platform agreement with Novartis, granting the Swiss pharmaceutical producer a non-exclusive license to its proprietary...

News

Takeda Sells Shire Eye Drug Xiidra to Novartis

13.05.2019 - To lighten its debt burden of more than $30 billion resulting from last year’s acquisition of Shire, Japanese pharma giant Takeda is selling Shire’s dry-eye drug Xiidra to...

News

Novartis and Amgen in Migraine Dispute

17.04.2019 - Swiss drugmaker Novartis and US biopharma Amgen are embroiled in a legal dispute regarding their collaboration on migraine prevention drug Aimovig. Novartis has filed a complaint...

Strategy & Management

The Need for Innovation in Pharmaceutical Manufacturing

08.04.2019 - The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...